Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Jazz Pharma Plc
(NQ:
JAZZ
)
166.90
USD
-6.60 (-3.80%)
Streaming Delayed Price
Updated: 9:32 AM EST, Feb 25, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Jazz Pharma Plc
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Jazz Pharmaceuticals Announces Participation at Cowen 41st Annual Healthcare Conference
February 23, 2021
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will webcast its corporate presentation at the Cowen 41st Annual Healthcare conference.
From
PR Newswire
Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2020 Financial Results
February 23, 2021
Highly Effective Operational Execution Drove Record Total Revenues
From
PR Newswire
PAO Group, Inc. Positions To Accelerate Growth; Investor Interest Pushes Shares 328% Higher YTD
February 23, 2021
Tags
Financial Market
Manufacturing & Industry
Health & Medicine
From
AB Newswire
Jazz Pharmaceuticals Announces Participation in the Leerink 10th Annual Global Healthcare Conference
February 17, 2021
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will webcast its corporate presentation at the Leerink 10th Annual Global Healthcare Conference.
From
PR Newswire
Jazz Pharmaceuticals Completes Submission of Supplemental New Drug Application for Xywav™ (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Idiopathic Hypersomnia
February 16, 2021
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the completion of the rolling submission for the supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) seeking...
From
PR Newswire
GW Pharmaceuticals plc Reports Fourth Quarter and Year-End 2020 Financial Results and Operational Progress
February 16, 2021
From
GlobeNewswire News Releases
420 with CNW — Jazz Pharmaceuticals (NASDAQ: JAZZ) to Acquire GW Pharmaceuticals (NASDAQ: GWPH) for $7.2 Billion
February 09, 2021
From
CannabisNewsWire
420 with CNW — Jazz Pharmaceuticals (NASDAQ: JAZZ) to Acquire GW Pharmaceuticals (NASDAQ: GWPH) for $7.2 Billion
February 09, 2021
From
InvestorBrandNetwork
Jazz Pharmaceuticals to Report 2020 Fourth Quarter Financial Results on February 23, 2021
February 09, 2021
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2020 fourth quarter and full year financial results on Tuesday, February 23, 2021, after the close of the financial...
From
PR Newswire
Lifshitz Law Firm, P.C. Announces Investigation of CNIG, GWPH, JAZZ, HOL, JWS, KTYB, SYBT, PRSP, PROS, and VIE
February 07, 2021
From
PR Newswire
Should you invest in Nio, Snap, Bank of America, Electronic Arts, or Jazz Pharmaceuticals?
February 05, 2021
InvestorsObserver issues critical PriceWatch Alerts for NIO, SNAP, BAC, EA, and JAZZ.
From
PR Newswire
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of GW Pharmaceuticals plc Buyout
February 03, 2021
From
GlobeNewswire News Releases
SHAREHOLDER ALERT: WeissLaw LLP Investigates GW Pharmaceuticals plc
February 03, 2021
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of GW Pharmaceuticals plc ("GWPH" or the "Company") (NASDAQ: GWPH) in connection...
From
PR Newswire
GW PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of GWPH and Encourages Investors to Contact the Firm
February 03, 2021
From
GlobeNewswire News Releases
Should you invest in Vaxart, Inovio Pharmaceuticals, Virgin Galactic, Blink Charging, or Jazz Pharmaceuticals?
February 03, 2021
InvestorsObserver issues critical PriceWatch Alerts for VXRT, INO, SPCE, BLNK, and JAZZ.
From
PR Newswire
Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader
February 03, 2021
Adds high-growth commercial franchise to Neuroscience portfolio with Epidiolex®, the first and only FDA-approved prescription cannabidiol medicine and a potential near-term blockbuster
From
PR Newswire
Jazz Pharmaceuticals Announces Participation in the 39th Annual J.P. Morgan Healthcare Conference
January 04, 2021
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will webcast its corporate presentation at the 39th Annual J.P. Morgan Healthcare Conference.
From
PR Newswire
Jazz Pharmaceuticals Announces Initiation of Biologics License Application Submission for JZP-458 for the Treatment of Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
December 21, 2020
Application to be reviewed under FDA's Oncology Center of Excellence Real-Time Oncology Review pilot program
From
PR Newswire
Rock Artist JIGI Is Back With a Jazz Rendition Of "Welcome (II V I)"
December 18, 2020
Tags
Jazz
Entertainment
Music
From
PRLog
Jazz Pharmaceuticals and PharmaMar Announce Results of ATLANTIS Phase 3 Study Evaluating Zepzelca™ in Combination with Doxorubicin for Patients with Small Cell Lung Cancer Following One Prior Platinum
December 03, 2020
Jazz Pharmaceuticals plc (Nasdaq: JAZZ), along with its partner, PharmaMar (MSE: PHM), today announce results from the ATLANTIS Phase 3 multicenter, randomized, controlled study evaluating Zepzelca™...
From
PR Newswire
Donald Wayne King Introduces New Lo-Fi Hip Hop Funk Sound
November 30, 2020
Tags
Lo/fi Hip Hop
Jazz
Jazz Music
From
PRLog
Jazz Pharmaceuticals Appoints Jennifer Cook and Mark Smith, M.D. to its Board of Directors
November 17, 2020
Non-executive directors bring significant leadership experience and healthcare expertise
From
PR Newswire
Jazz Pharmaceuticals Announces Participation at Jefferies Virtual London Healthcare Conference
November 10, 2020
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will webcast its corporate presentation at the following virtual healthcare conference:
From
PR Newswire
Data at ASH 2020 Annual Meeting Highlights Jazz Pharmaceuticals' Commitment to Advancing Hematology/Oncology Research
November 05, 2020
18 abstracts spanning Jazz's hematology/oncology therapeutic area to be presented
From
PR Newswire
Jazz Pharmaceuticals Announces Third Quarter 2020 Financial Results
November 02, 2020
Strong Financial and Operational Performance in Third Quarter 2020
From
PR Newswire
Jazz Pharmaceuticals Acquires SpringWorks Therapeutics' FAAH Inhibitor Program
October 26, 2020
Jazz Gains Exclusive Global Rights to FAAH Inhibitor PF-04457845 for the Potential Treatment of PTSD
From
PR Newswire
Jazz Pharmaceuticals Announces SLEEP Publication of Phase 3 Xywav™ (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Study in Cataplexy or Excessive Daytime Sleepiness in Patients wit
October 20, 2020
Xywav demonstrated highly statistically significant differences in median change in weekly number of cataplexy attacks and Epworth Sleepiness Scale scores compared to placebo
From
PR Newswire
Jazz Pharmaceuticals Announces Webcast for Xywav Investor Update
October 19, 2020
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will host a webcast on Monday, October 26, 2020 at 4:30 p.m. EDT / 8:30 p.m. GMT to provide investors with an update on Xywav™...
From
PR Newswire
Jazz Pharmaceuticals to Report 2020 Third Quarter Financial Results on November 2, 2020
October 19, 2020
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2020 third quarter financial results on Monday, November 2, 2020, after the close of the financial markets. Company...
From
PR Newswire
Orphan Drugs Market 2020 | Global Industry Overview, Sales Revenue, Demand and Opportunity 2025
October 15, 2020
Tags
Health & Medicine
From
AB Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.